Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-075214
Filing Date
2013-02-26
Accepted
2013-02-26 07:04:55
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d447199d10k.htm 10-K 1237329
2 EXHIBIT 23.1 d447199dex231.htm EX-23.1 1565
3 EXHIBIT 31.1 d447199dex311.htm EX-31.1 10003
4 EXHIBIT 31.2 d447199dex312.htm EX-31.2 10069
5 EXHIBIT 32.1 d447199dex321.htm EX-32.1 5285
12 GRAPHIC g447199g85y72.jpg GRAPHIC 61316
  Complete submission text file 0001193125-13-075214.txt   7998813

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vnda-20121231.xml EX-101.INS 1137249
7 XBRL TAXONOMY EXTENSION SCHEMA vnda-20121231.xsd EX-101.SCH 90722
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20121231_cal.xml EX-101.CAL 98475
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20121231_def.xml EX-101.DEF 388705
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20121231_lab.xml EX-101.LAB 568775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20121231_pre.xml EX-101.PRE 470657
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 13640976
SIC: 2834 Pharmaceutical Preparations